chr11-56176799-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005492.1(OR5J2):c.182T>A(p.Phe61Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000314 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005492.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5J2 | NM_001005492.1 | c.182T>A | p.Phe61Tyr | missense_variant | 1/1 | ENST00000312298.1 | NP_001005492.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5J2 | ENST00000312298.1 | c.182T>A | p.Phe61Tyr | missense_variant | 1/1 | 6 | NM_001005492.1 | ENSP00000310788.1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000259 AC: 65AN: 251282Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135808
GnomAD4 exome AF: 0.000321 AC: 469AN: 1461834Hom.: 0 Cov.: 33 AF XY: 0.000300 AC XY: 218AN XY: 727218
GnomAD4 genome AF: 0.000250 AC: 38AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2024 | The c.182T>A (p.F61Y) alteration is located in exon 1 (coding exon 1) of the OR5J2 gene. This alteration results from a T to A substitution at nucleotide position 182, causing the phenylalanine (F) at amino acid position 61 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at